advertisement
Martínez-de-la-Casa JM 21
Showing records 1 to 21 | Display all abstracts from Martínez-de-la-Casa JM70856 Charles Bonnet syndrome in a child with congenital glaucoma
Santos-Bueso E
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Andrés-Guerrero V
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Perucho-González L; Sáenz-Francés F
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Perucho-González L
Advances in Therapy 2017; 34: 378-395
70856 Charles Bonnet syndrome in a child with congenital glaucoma
Serrador-García M; Sáenz-Francés F
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Morales-Fernández L
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
García-Feijoo J; Morales-Fernández L
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Martínez-de-la-Casa JM
Acta Ophthalmologica 2017; 95: e107-e112
70856 Charles Bonnet syndrome in a child with congenital glaucoma
Méndez-Hernández C
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Méndez-Hernández CD
Acta Ophthalmologica 2017; 95: e107-e112
70856 Charles Bonnet syndrome in a child with congenital glaucoma
Morales-Fernández L
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Saenz-Francés F; Herrero-Vanrell R
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Santos-Bueso E
Acta Ophthalmologica 2017; 95: e107-e112
70856 Charles Bonnet syndrome in a child with congenital glaucoma
Martínez-de-la-Casa JM
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Júlvez LP
Advances in Therapy 2017; 34: 378-395
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
Brookes JL
Acta Ophthalmologica 2017; 95: e107-e112
70856 Charles Bonnet syndrome in a child with congenital glaucoma
García-Feijoo J
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Llorens VP
Advances in Therapy 2017; 34: 378-395
70856 Charles Bonnet syndrome in a child with congenital glaucoma
Porta-Etessam J
Archivos de la Sociedad Española de Oftalmologia 2017; 92: 398-400
70112 Structural and biomechanical corneal differences between patients suffering from primary congenital glaucoma and healthy volunteers
García-Feijoó J
Acta Ophthalmologica 2017; 95: e107-e112
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Martínez-de-la-Casa JM; Konstas AP
Advances in Therapy 2017; 34: 378-395
